Literature DB >> 9204336

Diagnostic value of MR imaging in comparison to CT in the detection and differential diagnosis of renal masses: ROC analysis.

B P Kreft1, H Müller-Miny, T Sommer, A Steudel, M Vahlensieck, D Novak, B G Müller, H H Schild.   

Abstract

The aim of this work was to compare MR imaging and CT in the detection of renal masses and in the differential diagnosis between benign and malignant lesions. In 33 patients with 54 renal lesions CT and MR images were evaluated by four readers with regard to tumor detection and characterization using a receiver-operating-characteristics (ROC) analysis. The MRI protocol consisted of a T1-weighted spin-echo (SE) sequence (TR/TE: 300/10 ms) before and after contrast administration and a heavily T2-weighted turbo-SE (TSE) sequence (TR/TE: 5500/150 ms). Az values for the area under the ROC curves for lesion detection were 0.92 +/- 0.04 for CT and 0.91 +/- 0.05 for MRI, respectively, which was not statistically different. The MRI technique was slightly, but not significantly, better than CT in the overall characterization (accuracy in differentiation between benign and malignant) of renal lesions with an Az value of 0.90 +/- 0.05 compared with 0.88 +/- 0.06 for CT. The MRI technique proved to be statistically superior to CT (p < 0.01) in the correct characterization of benign renal lesions. MRI equals CT in the overall detection and differential diagnosis of renal masses. MRI is very helpful for further differential diagnosis of lesions which are equivocal on CT especially in the differentiation between complicated cysts and cystic or hypovascular renal cell carcinoma.

Entities:  

Mesh:

Year:  1997        PMID: 9204336     DOI: 10.1007/s003300050200

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  12 in total

1.  MR Imaging of papillary renal neoplasms: potential application for characterization of small renal masses.

Authors:  Catherine Roy; Benoit Sauer; Véronique Lindner; Hervé Lang; Christian Saussine; Didier Jacqmin
Journal:  Eur Radiol       Date:  2006-06-07       Impact factor: 5.315

Review 2.  [Magnetic resonance imaging in urology. Current techniques].

Authors:  G Schneider; R Seidel; P Fries
Journal:  Urologe A       Date:  2004-11       Impact factor: 0.639

Review 3.  Total-body MR-imaging in oncology.

Authors:  Juergen F Schaefer; Heinz-Peter W Schlemmer
Journal:  Eur Radiol       Date:  2006-04-19       Impact factor: 5.315

4.  [Innovative imaging in urology: fascination and future. Yesterday, today, and tomorrow].

Authors:  T Loch; G Schneider
Journal:  Urologe A       Date:  2006-09       Impact factor: 0.639

5.  FDG-PET and CT characterization of adrenal lesions in cancer patients.

Authors:  Suman Jana; Tong Zhang; David M Milstein; Carmen R Isasi; M Donald Blaufox
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-09-29       Impact factor: 9.236

6.  Renal lesion characterization: clinical utility of single-phase dual-energy CT compared to MRI and dual-phase single-energy CT.

Authors:  Ali Pourvaziri; Amirkasra Mojtahed; Peter F Hahn; Michael S Gee; Avinash Kambadakone; Dushyant V Sahani
Journal:  Eur Radiol       Date:  2022-09-08       Impact factor: 7.034

Review 7.  Imaging of Solid Renal Masses.

Authors:  Fernando U Kay; Ivan Pedrosa
Journal:  Urol Clin North Am       Date:  2018-06-15       Impact factor: 2.241

Review 8.  [Modern imaging of kidney tumors].

Authors:  D-A Clevert; A Sterzik; M Braunagel; M Notohamiprodjo; A Graser
Journal:  Urologe A       Date:  2013-04       Impact factor: 0.639

Review 9.  Applications of positron emission tomography imaging, intraoperative ultrasonography, magnetic resonance imaging, and angiography in the evaluation of renal masses.

Authors:  R Houston Thompson; Robert P Hartman; Val J Lowe; Akira Kawashima; Bradley C Leibovich
Journal:  Curr Urol Rep       Date:  2004-02       Impact factor: 2.862

10.  Assessment and characterisation of common renal masses with CT and MRI.

Authors:  Leo Pallwein-Prettner; Daniel Flöry; Claus Raphael Rotter; Kurt Pogner; Gerhard Syré; Claudia Fellner; Ferdinand Frauscher; Friedrich Aigner; Frens Steffen Krause; Franz Fellner
Journal:  Insights Imaging       Date:  2011-07-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.